Acanthamoeba keratitis: risk factors and outcome.
作者信息
Hay J, Seal D V
出版信息
Br J Ophthalmol. 1996 Aug;80(8):773-4. doi: 10.1136/bjo.80.8.773.
Abstract
摘要
相似文献
1
Acanthamoeba keratitis: risk factors and outcome.
Br J Ophthalmol. 1996 Aug;80(8):773-4. doi: 10.1136/bjo.80.8.773.
2
Chemotherapy for acanthamoeba keratitis.
Lancet. 1995 Mar 25;345(8952):792.
3
[Good outcome in Acanthamoeba keratitis].
Ophthalmologe. 2017 Jul;114(7):653-655. doi: 10.1007/s00347-016-0350-5.
4
Drug therapy in a murine model of Acanthamoeba keratitis.
Eye (Lond). 1995;9 ( Pt 1):142-3. doi: 10.1038/eye.1995.24.
5
Acanthamoeba lenticulata keratitis in a hard contact lens wearer.
Clin Exp Ophthalmol. 2013 Nov;41(8):810-2. doi: 10.1111/ceo.12104. Epub 2013 Jun 3.
6
Treatment of Acanthamoeba keratitis.
S Afr Med J. 1996 May;86(5):566.
7
Misdiagnosis of orthokeratology-related Acanthamoeba keratitis as herpes simplex virus keratitis.
Clin Exp Ophthalmol. 2013 May-Jun;41(4):418-20. doi: 10.1111/ceo.12047.
8
Treatment of Acanthamoeba keratitis.
Eye (Lond). 1994;8 ( Pt 6):719-20. doi: 10.1038/eye.1994.191.
9
[Acanthamoeba keratitis, a possible dibromo propamidine isethionate resistance].
Arch Soc Esp Oftalmol. 2002 May;77(5):279-81.
10
[Treatment with a derivative of propamidine for keratitis in a user of soft lenses].
Med Clin (Barc). 1992 Oct 31;99(14):558-9.
引用本文的文献
1
In vitro amoebicidal activities of Satureja cuneifolia and Melissa officinalis on Acanthamoeba castellanii cysts and trophozoites.
Parasitol Res. 2012 Jun;110(6):2175-80. doi: 10.1007/s00436-011-2744-2. Epub 2011 Dec 9.
2
Acanthamoeba spp. as agents of disease in humans.
Clin Microbiol Rev. 2003 Apr;16(2):273-307. doi: 10.1128/CMR.16.2.273-307.2003.
本文引用的文献
1
Acanthamoeba keratitis: risk factors and outcome.
Br J Ophthalmol. 1995 Dec;79(12):1078-82. doi: 10.1136/bjo.79.12.1078.
2
A clinicopathologic study of in vitro sensitivity testing and Acanthamoeba keratitis.
Invest Ophthalmol Vis Sci. 1994 Mar;35(3):1059-64.
3
A review of 72 consecutive cases of Acanthamoeba keratitis, 1984-1992.
Eye (Lond). 1993;7 ( Pt 6):719-25. doi: 10.1038/eye.1993.168.
4
Chemotherapy for acanthamoeba keratitis.
Lancet. 1995 Mar 25;345(8952):791-2; author reply 792-3. doi: 10.1016/s0140-6736(95)90670-3.
5
Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
Eye (Lond). 1994;8 ( Pt 5):555-63. doi: 10.1038/eye.1994.137.
6
Chlorhexidine or polyhexamethylene biguanide for acanthamoeba keratitis.
Lancet. 1995 Jan 14;345(8942):136. doi: 10.1016/s0140-6736(95)90106-x.
7
Chlorhexidine effects on corneal epithelium and endothelium.
Arch Ophthalmol. 1980 Jul;98(7):1273-8. doi: 10.1001/archopht.1980.01020040125020.
8
Prolonged survival of Serratia marcescens in chlorhexidine.
Appl Environ Microbiol. 1981 Dec;42(6):1093-102. doi: 10.1128/aem.42.6.1093-1102.1981.
9
Antiseptic and antibiotic resistance in Gram-negative bacteria causing urinary tract infection.
J Clin Pathol. 1980 Mar;33(3):288-96. doi: 10.1136/jcp.33.3.288.
10
Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide.
Ophthalmology. 1992 Feb;99(2):185-91. doi: 10.1016/s0161-6420(92)31994-3.
Zotero 插件